Johnson & Johnson was awarded reimbursement for some expenses related to the case, but the judge ruled that ordering U.K.-based Drs. Antoni Nargol and David Langton to pay the devicemaker’s attorney fees “as an additional punishment would be excessive,” according to court documents.
The surgeons’ case was dismissed in December as a sanction for the misuse of confidential records. Both surgeons previously served as expert witnesses in a multidistrict litigation related to the hip implants and violated court orders by using information from those cases in their whistleblower suit.
The judge awarded Johnson & Johnson other fees, including some printing and docketing costs. The exact amount will be determined later.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
